Associate Professor of Health Policy and Management, University of Pittsburgh Health Sciences
Jarlenski's work advances knowledge about how policies may affect pregnancy and reproductive health. Currently, she leads a multi-disciplinary research group with Elizabeth Krans to investigate how to improve health outcomes for persons with opioid use disorders in pregnancy. She is Principal Investigator of two research projects: 1) research using real-world data to understand access to and quality of OUD treatment and pregnancy outcomes (R01DA045675), and 2) an implementation-effectiveness trial of a provider-level intervention to improve OUD treatment in pregnancy and subsequent outcomes (R01DA049759). Jarlenski also conducts work under an inter-governmental agreement to provide research support for the Pennsylvania Medicaid program, where she currently co-leads (with Dara Mendez) a Robert Wood Johnson Foundation funded project to study interventions to advance racial equity in pregnancy and birth outcomes. She has authored or co-authored more than 70 peer-reviewed publications, and her work has been cited by state and national policy-makers. Jarlenski earned her Ph.D. from the Johns Hopkins Bloomberg School of Public Health, M.P.H. from the Yale School of Public Health, and B.A. from Otterbein College.
Oct 31, 2022 08:43 am UTC| Health
The U.S. Food and Drug Administration is set to review a drugmakers application for the first over-the-counter birth control pill in November 2022, with a decision expected in the first half of 2023. An approved...
Johannesburg in a time of darkness: Ivan Vladislavić’s new memoir reminds us of the city’s fragility
Economist Chris Richardson on an ‘ugly’ inflation result and the coming budget
Why Germany ditched nuclear before coal – and why it won’t go back
Labour can afford to be far more ambitious with its economic policies – voters are on board
Sudan: civil war stretches into a second year with no end in sight